Update on Biological Therapies for Psoriasis

PROGRAM DESCRIPTION This webcast is intended to improve care of patients with psoriasis by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various ...

PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with psoriasis by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Assess diagnostic criteria and standard treatment options for early and moderate to severe patients with psoriasisIntegrate newer biological therapy with interleukin-17 (IL-17) and IL-23 pathway inhibitors in patients with moderate to severe psoriasis

---

Write the first review

Resource tags